RPG Life Sciences reported more than a three-hold jump in its first-quarter net profit.
CT Renganathan, managing director of the company spoke to CNBC-TV18 about the results and and the outlook .
“The sales grew by 8 percent, profitability has grown by almost 9 percent. Most of our businesses have been doing well,” he said.
“Our new products which we introduced in last few months, all of them are doing well,” he added.
“We are working on Ankleshwar plant. The site will go for auditing, we have already identified ourselves to the US-FDA and we are optimistic it will go to auditing by Q2 next year, 2019,” said Renganathan.